KatzungPharmacologyMCQs pdf Vasoactive peptides are a crucial class of signaling molecules in pharmacology, exerting significant effects on vascular smooth muscle and other tissues. These peptides act as autacoids, meaning they are locally produced and act near their site of release, playing vital roles in regulating blood pressure, inflammation, and various physiological processes.Proceedings of International Symposium on Vasoactive ... Understanding the pharmacology of vasoactive peptides, including their mechanisms of action, receptor interactions, and involvement in both health and disease, is essential for comprehending cardiovascular control and developing therapeutic strategies.
At their core, vasoactive peptides are peptides that influence blood vessel tone, either by causing constriction (vasoconstriction) or dilation (vasodilation). This broad category encompasses a diverse group of molecules, many of which are also recognized for their roles as hormones, neurotransmitters, or neuromodulators. They achieve their effects by binding to specific receptors, predominantly belonging to the seven transmembrane G-protein coupled receptor (GPCR) superfamily. This interaction triggers intracellular signaling cascades that ultimately alter vascular smooth muscle contraction or relaxation.Vasoactive peptides includepeptides that cause vasodilation or vasoconstrictionsuch as those in the renin-angiotensin system and kallikrein-kinin system.
The spectrum of vasoactive peptides is extensive, with at least 16 naturally occurring peptides identified as influencing vascular tone. They can be broadly categorized by their primary effect:
* Vasoconstrictors: These peptides narrow blood vessels, leading to increased blood pressureVasoactive Peptides. Prominent examples include angiotensin II, vasopressin, endothelins, neuropeptide Y, and urotensin.
* Vasodilators: These peptides widen blood vessels, resulting in decreased blood pressure. Key examples include kinins (such as bradykinin, BK), natriuretic peptides (like atrial natriuretic peptide, ANP), and vasoactive intestinal peptide (VIP).
Several well-established peptide systems are central to understanding vasoactive peptide pharmacology:
* The Renin-Angiotensin System (RAS): This system is a cornerstone of blood pressure regulation.Vasoactive peptides, their receptors and drug development Angiotensin II, a potent vasoconstrictor, is a key effector peptide. Its production is tightly controlled, and its effects are mediated through specific angiotensin receptors (AT1 and AT2). Pharmacological interventions targeting the RAS, such as ACE inhibitors and angiotensin receptor blockers, are widely used to manage hypertension and heart failure. Angiotensin II also plays a role in inhibiting renin secretion, demonstrating a negative feedback mechanism.At least 16 naturally occurring peptideseither constrict or dilate blood vessels. Many of these peptides are present in nerve cells and nerve terminals.
* The Kallikrein-Kinin System (KKS): This system is primarily associated with vasodilation and inflammatory responses. Kinins, such as bradykinin, are potent vasodilators that can significantly lower arterial blood pressure.Vasoactive peptides. State-of-the-art review. | Hypertension They also modulate the tone of salivary glands and can influence gastrointestinal function. The pharmacological manipulation of the KKS is an area of ongoing research for conditions involving vasodilation and inflammation.
* Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP): These neuropeptides, composed of 28 amino acids, are widely distributed and have diverse functions.Chapter 10. Endogenous Vasoactive Peptides In the periphery, VIP and PACAP are crucial in regulating immunity and inflammation, controlling pancreatic insulin secretion, and modulating vascular tone, often leading to vasodilationVasoactive peptides | PPTX. They act via specific G protein-coupled receptors, influencing cellular processes beyond just vascular smooth muscleVasoactive peptides arekey autacoids with significant roles in regulating vascular smooth muscle, including vasoconstrictors like angiotensin II and .... VIP has also shown potential in preventing excitotoxic cell death in the developing brainPharmacology and functions of receptors for vasoactive ....
* Endothelins: These are potent vasoconstrictor peptides produced by endothelial cells. They play a significant role in maintaining basal vascular tone and are implicated in various cardiovascular diseases, including pulmonary hypertension.
* Natriuretic Peptides: Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are released from the heart in response to volume or pressure overloadPharmacology and functions of receptors for vasoactive ... - PMC. They promote vasodilation, natriuresis, and diuresis, counteracting the effects of vasoconstrictors and contributing to fluid and blood pressure homeostasisVasoactive peptides as mediators of increased vascular ....
The diverse actions of vasoactive peptides are mediated through their specific interactions with cell surface receptors. As mentioned, most of these receptors are GPCRs. Upon ligand binding, GPCRs undergo conformational changes that activate intracellular G proteins, initiating a cascade of signaling events. These events can include:
* Activation of adenylyl cyclase: Leading to increased intracellular cyclic AMP (cAMP) levels, often resulting in smooth muscle relaxation.
* Activation of phospholipase C: Leading to increased intracellular inositol trisphosphate (IP3) and diacylglycerol (DAG), which can mobilize intracellular calcium and promote smooth muscle contraction.
* Modulation of ion channels: Affecting membrane potential and cellular excitability.Angiotensin II inhibits renin secretion: Sympathetic nervous system Norepinephrine (direct action on juxtaglomerular cells) increases renin release.
The specificity of these interactions is crucial.Chapter 17: Vasoactive Peptides - AccessPharmacy For instance, angiotensin II exerts its major vasoconstrictive effects primarily through the AT1 receptor, while the AT2 receptor may mediate counter-regulatory effects. Similarly, different kinin receptors mediate distinct physiological responses. The detailed understanding of these receptor-ligand interactions is fundamental to drug development, aiming to selectively target specific pathways to achieve desired therapeutic outcomes while minimizing off-target effects.There is evidence for the participation of at least some vasoactive peptidesin the regulation of these functions and in the mediation or modulation of ...
The pharmacology of vasoactive peptides has profound clinical implications. Dysregulation of these peptide systems is implicated in a wide array of pathological conditions, including:
* Hypertension: Overactivity of the renin-angiotensin system and imbalances in vasoconstrictor/vasodilator peptide levels contribute to elevated blood pressure.
* Heart Failure: Alterations in natriuretic peptide systems and the renin-angiotensin system are key features of heart failure.作者：H Kusserow·2004·被引用次数：35—The peptides act via specific receptors, most of them belonging to the group of seven transmembrane G-protein coupled receptors.
* Inflammatory Diseases: Vasoactive peptides like kinins and VIP play roles in mediating inflammatory processes.
* Pulmonary Hypertension: Endothelins are particularly implicated in the pathogenesis of this conditionEffects on Smooth Muscle Preparations of Unidentified ....
Targeting vasoactive peptide systems has yielded highly effective therapeutic agents. Beyond the established RAS inhibitors, research continues into developing novel drugs that modulate other vasoactive peptide pathways. This includes exploring antagonists for endothelin receptors, agonists for natriuretic peptide receptors, and modulators of kinin pathways for conditions ranging from cardiovascular disease to pain and inflammation. Furthermore, some vasoactive peptides may serve as cotransmitters with neurotransmitters like acetylcholine and noradrenaline, indicating complex interactions at both pre- and postjunctional levels that influence autonomic nervous system function作者：H Kusserow·2004·被引用次数：35—The peptidesact via specific receptors, most of them belonging to the group of seven transmembrane G-protein coupled receptors..
In conclusion, vasoactive peptides represent a vital and complex area of pharmacology. Their diverse roles in regulating vascular tone, blood pressure, and numerous other physiological processes underscore their importance作者：LM Greenbaum·1977·被引用次数：8—Large peptides, specifically the leukokinins and vasoactive intestinal peptide,can alter normal body functionsparticularly with respect to vascular .... Continued research into their intricate mechanisms of action and receptor pharmacology promises to unlock new therapeutic avenues for a wide spectrum of human diseases.
Join the newsletter to receive news, updates, new products and freebies in your inbox.